Literature DB >> 27544802

Pancreatic involvement by mesenchymal chondrosarcoma harboring the HEY1-NCOA2 gene fusion.

Jarish N Cohen1, David A Solomon1, Andrew E Horvai1, Sanjay Kakar2.   

Abstract

Mesenchymal chondrosarcoma (MC) is an aggressive small, round, blue cell tumor with chondrogenic differentiation that typically arises in bony sites. Approximately, a third of these tumors develop in extraskeletal sites such as the meninges, and somatic soft tissue. The MCs are well-circumscribed, lobulated masses, with focal calcification. Histologically, 2 distinct populations of neoplastic cells characterize MC: sheets of primitive small, round, blue cells surrounding islands of well-developed hyaline cartilage with mature chondrocytes in lacunae. Involvement of the gastrointestinal tract and pancreas by primary or metastatic MC is a relatively rare occurrence. We identified 8 patients with MC in our departmental archives from 1990 to 2015, two of which had pancreatic involvement. The patients were young women who developed masses in the distal pancreas. Molecular testing demonstrated that both tumors harbored the recently described HEY1-NCOA2 gene fusion. These cases illustrate that pancreatic involvement can occur in MC, and the demonstration of HEY1-NCOA2 fusion can be helpful to confirm the diagnosis. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biphasic; Gene fusion; HEY1-NCOA2; Mesenchymal chondrosarcoma; Pancreas

Mesh:

Substances:

Year:  2016        PMID: 27544802     DOI: 10.1016/j.humpath.2016.07.026

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

1.  A Rare Case Report of Mesenchymal Chondrosarcoma with Pancreatic Metastasis.

Authors:  Jian-Jiun Chen; Cheng-Wei Chou
Journal:  Medicina (Kaunas)       Date:  2022-05-05       Impact factor: 2.948

2.  Mesenchymal chondrosarcoma metastasising to the pancreas.

Authors:  Christoph Paasch; Gianluca De Santo; Katherina Renate Boettge; Martin W Strik
Journal:  BMJ Case Rep       Date:  2018-12-31

Review 3.  Interstitial Deletions Generating Fusion Genes.

Authors:  Ioannis Panagopoulos; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2021 May-Jun       Impact factor: 4.069

Review 4.  Current Approaches for Personalized Therapy of Soft Tissue Sarcomas.

Authors:  Kirill I Kirsanov; Ekaterina A Lesovaya; Timur I Fetisov; Beniamin Yu Bokhyan; Gennady A Belitsky; Marianna G Yakubovskaya
Journal:  Sarcoma       Date:  2020-03-31

5.  Intracranial Mesenchymal Chondrosarcoma Lacking the Typical Histopathological Features Diagnosed by HEY1-NCOA2 Gene Fusion.

Authors:  Atsuhito Uneda; Kazuhiko Kurozumi; Atsushi Fujimura; Atsunori Kamiya; Takanori Hirose; Hiroyuki Yanai; Isao Date
Journal:  NMC Case Rep J       Date:  2020-03-24

6.  Genomic profiling identifies genes and pathways dysregulated by HEY1-NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis.

Authors:  Wenqing Qi; Wojciech Rosikiewicz; Zhaohong Yin; Beisi Xu; Huihong Jiang; Shibiao Wan; Yiping Fan; Gang Wu; Lu Wang
Journal:  J Pathol       Date:  2022-04-26       Impact factor: 9.883

7.  Primary mesenchymal chondrosarcoma of the kidney without HEY1-NCOA2 and IRF2BP2-CDX1 fusion: A case report and review.

Authors:  Atsushi Yamagishi; Osamu Ichiyanagi; Sei Naito; Hiromi Ito; Takanobu Kabasawa; Mitsunori Yamakawa; Norihiko Tsuchiya
Journal:  Oncol Lett       Date:  2019-11-22       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.